Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2019
30-04-19 kl. 30/4 2019 17:18 | Novo Nordisk A/s 46,52 (+0,65%)
Se flere nyheder om Novo Nordisk A/s
Bagsværd, Denmark, 30 April 2019 - In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.
Referring to Company Announcement no 24/2019 dated 24 April 2019, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 30 April 2019.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | [email protected] |
| Ken Inchausti (US) | +1 609 786 8316 | [email protected] |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | [email protected] |
| Valdemar Borum Svarrer | +45 3079 0301 | [email protected] |
| Ann Søndermølle Rendbæk | +45 3075 2253 | [email protected] |
| Kristoffer Due Berg (US) | +1 609 235 2989 | [email protected] |
Company announcement no. 28 / 2019
20190430_Voting rights_UK
Apr 30, 2019
Der er endnu ikke skrevet nogen kommentarer til denne artikel.
Skriv en kommentarer til denne artikel:
Send kommentar
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 46,52 |
|---|---|
| ÆNDRING | +0,30 (+0,65%) |
| ÅBEN | 46,47 |
| SIDSTE LUK | 0,00 |
| DEBAT | - |
 |
